Brazil moves to limit medtech mercury use
This article was originally published in Clinica
Executive Summary
Brazil is seeking to restrict the use of mercury in medical devices, in line with healthcare safety and manufacturing policies in other countries. Regulatory agency Anvisa yesterday hosted a “technical panel” consisting of representatives from the medtech industry, the health services, academia and the government.